Hemex Health awarded $3 million grant to advance commercialization of Gazelle Hb Variant Test for the U.S. market

Hemex Health, a medical diagnostic device company focused on expanding healthcare access to underrepresented patient populations, announced it has been awarded a 3-year, $3 million grant from the National Heart, Lung, and Blood Institute.

Related Keywords

India ,United States ,American ,Americans ,Emily Henderson ,Patti White ,Stephen Boateng ,National Institutes Of Health ,National Heart ,Blood Institute ,Hemex Health ,American Society Of Hematology ,National Institutes ,Sickle Cell Disease ,Sickle Cell ,Middle East ,Industry Focus ,Southeast Asian ,American Society ,Cell ,Flood ,Iagnostic ,Disability ,Enetic ,Healthcare ,Heart ,Rain ,Research ,Thalassemia ,